We advised the US private equity firm Warburg Pincus in relation to its USD 130 million investment in Oxylabs, a leading data infrastructure platform. Following this investment, the total valuation of Oxylabs will reach USD 3.6 billion making it Lithuania’s second-largest unicorn by valuation and the sixth unicorn to originate from Lithuania.
“Oxylabs has established itself as a leader in web intelligence through its sophisticated technology and expansive network,” in official press release said Allison Ross, Principal, Warburg Pincus. “We are excited to support the Oxylabs team as they continue to expand their offering to help their blue-chip customers access and unlock data-driven insights.”
Oxylabs is a leading global data infrastructure platform purpose-built for the AI era, providing foundational components of the search and web intelligence ecosystem and the next generation of AI models, agents, and enterprise systems. With over 350,000 customers, Oxylabs has established itself as a critical enabler of large-scale data acquisition across the cybersecurity, e-commerce, and financial industries. From its origins as a premium proxy service, the company is evolving into a full-stack web-data infrastructure platform that empowers AI systems to reliably access, interpret, and act on the open web at scale while delivering trusted, structured data to leading Fortune 500 companies.
Our team and services
In cooperation with Latham & Watkins, we advised the client on all matters of Lithuanian law related to the transaction, including the legal due diligence of the target companies and advice on transaction documents.
Our team was led by partner Laimonas Skibarka and senior associate Aliaksei Vashkevich, with key contributions from partner Kazimieras Karpickis, counsel Ignas Sidaras, associates Beatričė Zubytė, Guoda Vdovycytė, Ieva Tučkutė, Nojus Jašmontas and other our experts.
